Kenji Tabata

688 total citations
29 papers, 561 citations indexed

About

Kenji Tabata is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Kenji Tabata has authored 29 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Kenji Tabata's work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Kenji Tabata is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Kenji Tabata collaborates with scholars based in Japan, United States and China. Kenji Tabata's co-authors include Kiyoshi Yamaoka, Toshio Teramura, Shigeyuki Terashita, Atsunori Kaibara, Terumichi Nakagawa, Takehisa Hata, Shingo Suzuki, Akio Kawamura, Shohei Sakuda and Masataka Katashima and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences and Analytical and Bioanalytical Chemistry.

In The Last Decade

Kenji Tabata

29 papers receiving 539 citations

Peers

Kenji Tabata
I. Gardner United Kingdom
Jignesh Patel United States
Frank W. Lee United States
John R. Strauss United States
James B. Mangold United States
Justin D. Lutz United States
Kenji Tabata
Citations per year, relative to Kenji Tabata Kenji Tabata (= 1×) peers Yasushi Yoshigae

Countries citing papers authored by Kenji Tabata

Since Specialization
Citations

This map shows the geographic impact of Kenji Tabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Tabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Tabata more than expected).

Fields of papers citing papers by Kenji Tabata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Tabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Tabata. The network helps show where Kenji Tabata may publish in the future.

Co-authorship network of co-authors of Kenji Tabata

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Tabata. A scholar is included among the top collaborators of Kenji Tabata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Tabata. Kenji Tabata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabata, Kenji, et al.. (2019). An introduction to QSP modeling for pharmacologists. Folia Pharmacologica Japonica. 154(3). 143–150. 2 indexed citations
2.
Minematsu, Tsuyoshi, et al.. (2019). Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment. Biopharmaceutics & Drug Disposition. 40(5-6). 176–187. 6 indexed citations
3.
Nozawa, Takashi, et al.. (2018). The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein. Journal of Pharmaceutical Sciences. 108(3). 1085–1089. 3 indexed citations
5.
Tabata, Kenji, et al.. (2017). Quantitative LC/ESI-SRM/MS of antibody biopharmaceuticals: use of a homologous antibody as an internal standard and three-step method development. Analytical and Bioanalytical Chemistry. 409(23). 5523–5532. 9 indexed citations
6.
Nozawa, Takashi, et al.. (2015). Development and Validation of Semiautomated 96-Well Transport Assay Using LLC-PK1 Cells Transfected with Human P-Glycoprotein for High-Throughput Screening. Assay and Drug Development Technologies. 13(2). 79–87. 3 indexed citations
7.
Naritomi, Yoichi, et al.. (2014). Prediction of hepatic and intestinal glucuronidation using in vitro–in vivo extrapolation. Drug Metabolism and Pharmacokinetics. 30(1). 21–29. 26 indexed citations
8.
Naritomi, Yoichi, Kazuhiro Tetsuka, Hiroyuki Moriguchi, et al.. (2013). Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys. Xenobiotica. 44(3). 205–216. 22 indexed citations
10.
Tabata, Kenji, et al.. (2010). Quantitative Prediction of Intestinal Metabolism in Humans from a Simplified Intestinal Availability Model and Empirical Scaling Factor. Drug Metabolism and Disposition. 38(7). 1230–1237. 43 indexed citations
11.
Tabata, Kenji, et al.. (2009). A Comparison of Pharmacokinetics between Humans and Monkeys. Drug Metabolism and Disposition. 38(2). 308–316. 77 indexed citations
12.
Tabata, Kenji, et al.. (2009). Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research. European Journal of Drug Metabolism and Pharmacokinetics. 34(2). 117–128. 8 indexed citations
13.
Tabata, Kenji, Masataka Katashima, Akio Kawamura, Atsunori Kaibara, & Yusuke Tanigawara. (2006). Population Pharmacokinetic Analysis of Micafungin in Japanese Patients with Fungal Infections. Drug Metabolism and Pharmacokinetics. 21(4). 324–331. 23 indexed citations
14.
Tabata, Kenji, Masataka Katashima, Akio Kawamura, Akira Kagayama, & Shigeru Kohno. (2006). Pharmacokinetics-pharmacodynamics of micafungin in Japanese patients with deep-seated mycosis. European Journal of Drug Metabolism and Pharmacokinetics. 31(2). 123–128. 11 indexed citations
15.
Morishita, Yoshihiko, Yoshitaka Hirayama, Kikuo Miyayasu, et al.. (2005). FK506 Aerosol Locally Inhibits Antigen-Induced Airway Inflammation in Guinea Pigs. International Archives of Allergy and Immunology. 136(4). 372–378. 9 indexed citations
16.
Niwa, Toshiro, et al.. (2004). [Development of software for data analysis by therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic].. PubMed. 57(4). 413–9. 4 indexed citations
18.
Tabata, Kenji, et al.. (1996). Influence of Pentobarbitone on In-vivo Local Disposition of Diclofenac in Rat Liver. Journal of Pharmacy and Pharmacology. 48(8). 866–869. 7 indexed citations
20.
Yamaoka, Kosaku, et al.. (1995). Influence of Laparotomy on Disposition Kinetics of Diclofenac in CCl4-Intoxicated Rats.. Biological and Pharmaceutical Bulletin. 18(2). 251–255. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026